Daniel Van Langenberg

23PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Condensed matter characterisation technique developmentMedical bacteriologyGene and molecular therapyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 28, 2025
Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Paulina Suo, Ashish Srinivasan, Lena Thin

|Sep 05, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.

Natalie Yu, Tanya Lee, Daniel Tassone

|Jan 01, 2024
Utility of panenteric capsule endoscopy for the detection of small-bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study.

Anuj Bohra, Diana Lewis, Jonathan P Segal

|Dec 14, 2023
Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).

Abhinav Vasudevan, Danny Con, Peter De Cruz

|Jan 24, 2023
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses.

Ashish Srinivasan, Peter De Cruz, Melissa Sam

|Feb 11, 2021
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.

Ayushi Chauhan, Ross Apostolov, Daniel van Langenberg

Pageof 4

Frequent Collaborators

9 joint publications

Abhinav Vasudevan

5 joint publications

Ashish Srinivasan

5 joint publications

Danny Con

3 joint publications

Steven Nicolaides